You just read:

Janssen Enters Into Worldwide Collaboration With Theravance Biopharma For Oral, Pan-JAK Inhibitor Drug Candidate For The Treatment Of Inflammatory Bowel Disease

News provided by

Janssen Pharmaceutical Companies

Feb 07, 2018, 07:30 ET